1. Induced Disease Models Products
  2. Immunology and Inflammatory Disease Models
  3. Liver Inflammation Model

Liver Inflammation Model

Liver Inflammation Model (3):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-D1056
    Lipopolysaccharides, from E. coli O55:B5
    Lipopolysaccharides (LPS) is an endotoxin derived from the outer leaflet of the outer membrane of Gram-negative bacteria. Lipopolysaccharides consists of an antigen O-specific chain, a core oligosaccharide and lipid A. Lipopolysaccharides is a pathogenic associated molecular pattern (PAMP) that activates the immune system. Lipopolysaccharides activates TLR-4 on immune cells. This product is derived from Escherichia coli O55:B5. Lipopolysaccharides induces secretion of cell migrasome.
    Lipopolysaccharides, from E. coli O55:B5
  • HY-B0172
    Lithocholic acid 434-13-9 99.99%
    Lithocholic acid is a toxic secondary bile acid that can promote intrahepatic cholestasis and promote tumorigenesis. Lithocholic acid is also a FXR antagonist and a PXR/SXR agonist.
    Lithocholic acid
  • HY-42682
    D(+)-Galactosamine hydrochloride 1772-03-8 ≥98.0%
    D(+)-Galactosamine (D-Galactosamine) hydrochloride, which is an established experimental toxin, primarily causes liver injury by the generation of free radicals and depletion of UTP nucleotides. D(+)-Galactosamine hydrochloride intoxication also induces renal dysfunction thus, renal failure is often associated with the end-stage of the liver damage. Lipopolysaccharide/D(+)-Galactosamine-induced acute liver injury is a known animal model of fulminant hepatic failure.
    D(+)-Galactosamine hydrochloride